Jonathan M. Pratt

QIAGEN N.V. has appointed Jonathan M. Pratt as Chief Executive Officer, bringing more than 25 years of international leadership experience across life sciences, laboratory technologies, and healthcare.

Pratt most recently served as President and CEO of Filtration Group, where he led the business through the completion of its sale to Parker-Hannifin Corporation in August 2026. Previously, he served as Senior Vice President of the Waters Division at Waters Corporation and as President of Beckman Coulter Life Sciences, a Danaher operating company. He also held several senior leadership positions at Pall Corporation.

Throughout his career, Pratt has led global businesses spanning analytical instruments, laboratory technologies, software, consumables, services, and bioprocessing applications. His experience includes commercial strategy and execution, portfolio management, operations, and organizational development across markets closely connected to QIAGEN’s products and customer workflows.

QIAGEN said Pratt was selected following a comprehensive search process, based on his global industry knowledge, international leadership experience, and track record of improving performance across global businesses.

As part of the appointment, Pratt will be proposed for shareholder approval as a Managing Director at an Extraordinary General Meeting expected to take place in the fourth quarter of 2026.

Thierry Bernard will step down as CEO and Managing Director and will support an orderly leadership transition through the end of 2026.